Yüklüyor......
Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKCδ Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP
New therapeutic strategies are needed for cutaneous T-cell lymphoma (CTCL), and the plant extract ingenol mebutate (PEP005) may be considered. PEP005 has been approved for actinic keratosis, and proapoptotic activities were described in different cancer cells. Here, we aimed to investigate its effic...
Kaydedildi:
| Yayımlandı: | Cells |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8146015/ https://ncbi.nlm.nih.gov/pubmed/33922439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10050987 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|